NeuroSense Therapeutics Ltd. (NRSN)

NeuroSense Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.38	2.64	3.54	11.06	0.7
Short-Term Investments	-	-	3.55	-	-
Cash & Short-Term Investments	3.38	2.64	7.09	11.06	0.7
Cash Growth	27.96%	-62.76%	-35.91%	1482.69%	-21.90%
Other Receivables	0.16	0.17	0.13	0.18	0.03
Receivables	0.16	0.17	0.13	0.18	0.03
Inventory	0.74	-	-	-	-
Prepaid Expenses	0.09	0.07	0.12	0.13	-
Other Current Assets	0.04	0.04	0.04	0.04	0.04
Total Current Assets	4.4	2.92	7.38	11.41	0.77
Property, Plant & Equipment	0.15	0.25	0.31	0.02	0.01
Other Long-Term Assets	0.02	0.02	0.02	-	-
Total Assets	4.58	3.19	7.72	11.43	0.78
Accounts Payable	1.16	1.46	0.5	0.04	0.06
Accrued Expenses	0.76	1.93	1.16	0.56	0.07
Current Portion of Leases	0.07	0.07	0.06	-	-
Total Current Liabilities	1.99	3.46	1.73	0.6	0.12
Long-Term Leases	-	0.07	0.15	-	-
Other Long-Term Liabilities	-	1.41	-	1.83	-
Total Liabilities	1.99	4.94	1.87	2.43	0.12
Additional Paid-In Capital	39.24	24.36	21.86	17.45	5.06
Retained Earnings	-36.66	-26.12	-16.01	-8.45	-4.41
Shareholders' Equity	2.58	-1.76	5.84	9.01	0.66
Total Liabilities & Equity	4.58	3.19	7.72	11.43	0.78
Total Debt	0.07	0.14	0.21	-	-
Net Cash (Debt)	3.31	2.5	6.88	11.06	0.7
Net Cash Growth	32.31%	-63.69%	-37.82%	1482.69%	-21.90%
Net Cash Per Share	0.18	0.18	0.60	1.77	0.13
Filing Date Shares Outstanding	23.99	15.6	11.79	10.94	5.82
Total Common Shares Outstanding	23.23	15.38	11.78	10.94	5.58
Working Capital	2.41	-0.54	5.66	10.82	0.65
Book Value Per Share	0.11	-0.11	0.50	0.82	0.12
Tangible Book Value	2.58	-1.76	5.84	9.01	0.66
Tangible Book Value Per Share	0.11	-0.11	0.50	0.82	0.12
Machinery	0.12	0.12	0.09	0.02	0.01
Leasehold Improvements	0	0	0	-	0.01

Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q